• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草酸钙结晶尿症:尿液中的晶体大小

Calcium oxalate crystalluria: crystal size in urine.

作者信息

Elliot J S, Rabinowitz I N

出版信息

J Urol. 1980 Mar;123(3):324-7. doi: 10.1016/s0022-5347(17)55918-2.

DOI:10.1016/s0022-5347(17)55918-2
PMID:7359628
Abstract

Studies of calcium oxalate crystals in urine suggest similarities to crystal growth in calcium oxalate renal calculi. Previous reports indicate that urinary crystals in patients in whom stones form are larger than those in normal subjects. We report herein a study on crystal size by structure and habit (shape) based on direct microscopic measurement of crystals in urine of 27 normal subjects and in 6 of 22 patients in whom stones form. The mean size of all crystals in normal subjects is 12.0 plus or minus 7.8 micrometers. Calcium oxalate monohydrate crystals are significantly smaller than calcium oxalate dihydrate (p less than 0.01). In 22 patients with stones there was no correlation between crystalluria and severity or duration of disease. The mean crystal size in 6 patients did not support the conclusion that patients in whom stones form excrete larger crystals than normal subjects.

摘要

对尿中草酸钙晶体的研究表明,其与草酸钙肾结石中的晶体生长存在相似性。先前的报告指出,形成结石的患者尿中的晶体比正常受试者的更大。我们在此报告一项基于对27名正常受试者以及22名结石形成患者中的6名患者尿液中的晶体进行直接显微镜测量,关于晶体大小按结构和习性(形状)的研究。正常受试者中所有晶体的平均大小为12.0±7.8微米。一水合草酸钙晶体明显小于二水合草酸钙晶体(p<0.01)。在22名结石患者中,结晶尿与疾病的严重程度或病程之间无相关性。6名患者的平均晶体大小并不支持结石形成患者排出的晶体比正常受试者更大这一结论。

相似文献

1
Calcium oxalate crystalluria: crystal size in urine.草酸钙结晶尿症:尿液中的晶体大小
J Urol. 1980 Mar;123(3):324-7. doi: 10.1016/s0022-5347(17)55918-2.
2
Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.结石患者和正常受试者肾尿与膀胱尿中草酸钙结晶尿的研究。
Urol Int. 1998;60(1):41-6. doi: 10.1159/000030201.
3
Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.白蛋白介导的草酸钙晶体成核作用:对预防结石形成的影响。
Kidney Int. 1999 May;55(5):1776-86. doi: 10.1046/j.1523-1755.1999.00426.x.
4
Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.肾结石中草酸钙二水合物的代谢性尿液相关因素。
J Urol. 1998 Mar;159(3):664-8.
5
Calcium oxalate crystalluria in elderly patients and treatment with naftidrofuryl oxalate.
Age Ageing. 1995 Nov;24(6):464-7. doi: 10.1093/ageing/24.6.464.
6
Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.尿液稀释对草酸盐负荷体外诱导的草酸钙晶体数量、大小和聚集的影响。
Clin Chem Lab Med. 2005;43(6):585-9. doi: 10.1515/CCLM.2005.102.
7
[Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].[尿枸橼酸盐水平对自发性二水草酸钙结晶尿的影响]
Prog Urol. 2005 Sep;15(4):650-5.
8
Studies on crystalluria in calcium oxalate stone formers.草酸钙结石患者的结晶尿研究。
Urol Res. 1984;12(2):103-6. doi: 10.1007/BF00257173.
9
Low specific gravity urine with crystalluria as discriminant index for nephrolithiasis.以低比重尿伴结晶尿作为肾结石的鉴别指标。
J Med Assoc Thai. 1990 Nov;73(11):634-40.
10
Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones.单纯一水草酸钙和二水草酸钙肾结石患者的临床及生化差异
J Urol. 1994 Mar;151(3):571-4. doi: 10.1016/s0022-5347(17)35017-6.

引用本文的文献

1
Diversity and distribution of extracellular microcrystals in holothuroid echinoderms.海参纲棘皮动物细胞外微晶的多样性与分布
R Soc Open Sci. 2025 Sep 17;12(9):250514. doi: 10.1098/rsos.250514. eCollection 2025 Sep.
2
Cooling-induced brushite crystallization in urine as a predictive risk marker for calcium kidney stone recurrence.尿液中冷却诱导的透钙磷石结晶作为肾结石复发的预测风险标志物。
Urolithiasis. 2025 Sep 6;53(1):172. doi: 10.1007/s00240-025-01820-2.
3
Linking basic principles of solution chemistry to kidney stone formation timelines.
将溶液化学的基本原理与肾结石形成时间线联系起来。
Sci Rep. 2025 Jul 1;15(1):20625. doi: 10.1038/s41598-025-07193-1.
4
Characterizing the particulate content of urine in healthy humans using flow cytometry.运用流式细胞术对健康人体尿液中的微粒成分进行表征。
PLoS One. 2025 May 22;20(5):e0324271. doi: 10.1371/journal.pone.0324271. eCollection 2025.
5
Exploring the association between multiple factors and urolithiasis: A retrospective study and Mendelian randomization analysis.探索多种因素与尿石症之间的关联:一项回顾性研究和孟德尔随机化分析。
Medicine (Baltimore). 2024 May 3;103(18):e37968. doi: 10.1097/MD.0000000000037968.
6
Antioxidant activity and Inhibitory effects of Cydonia oblonga Miller. leaves extracts against calcium oxalate stones.黑枣叶提取物的抗氧化活性及其对草酸钙结石的抑制作用。
Urolithiasis. 2024 Apr 10;52(1):62. doi: 10.1007/s00240-024-01532-z.
7
Carboxymethylated Polysaccharides Regulate Calcium Oxalate Crystals Growth and Reduce the Regulated Crystals' Cytotoxicity.羧甲基多糖调节草酸钙晶体生长并降低调控晶体的细胞毒性。
Biomolecules. 2023 Jun 27;13(7):1044. doi: 10.3390/biom13071044.
8
Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.肾脏草酸钙晶体沉积:鉴定、病因与后果。
Urolithiasis. 2020 Oct;48(5):377-384. doi: 10.1007/s00240-020-01202-w. Epub 2020 Jul 27.
9
What does the crystallography of stones tell us about their formation?结石的晶体结构能告诉我们它们是如何形成的?
Urolithiasis. 2017 Feb;45(1):11-18. doi: 10.1007/s00240-016-0951-0. Epub 2016 Nov 29.
10
Immunohistochemical localization and mRNA quantification of osteopontin and Tamm-Horsfall protein in canine renal tissue after potassium oxalate injection.草酸钾注射后犬肾组织中骨桥蛋白和Tamm-Horsfall蛋白的免疫组化定位及mRNA定量分析
BMC Vet Res. 2014 Mar 17;10:70. doi: 10.1186/1746-6148-10-70.